Remove company press
article thumbnail

BioNTech hit with 'notice of default' from NIH in COVID-19 vaccine royalty dispute

Fierce Pharma

officials are pressing the company to pay royalties linked to the commercialization of its lucrative Pfizer-partnered COVID-19 vaccine. Even as Germany's BioNTech deals with ongoing declines of its revenue and share price, it's facing another serious concern: U.S.

Vaccines 141
article thumbnail

New Epic, Press Ganey integration automates nursing quality, safety data reporting

Fierce Healthcare

Patient experience monitoring company Press Ganey has taken its data integration partnership with Epic a step further, unveiling Monday an additional collaboration focused on nursing-related safety | Indicators and outcomes logged in the EHR platform will be pulled into Press Ganey's National Database of Nursing Quality Indicators, which is used (..)

88
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: Microsoft is selling AI in health care, and helping to set its standards. Is that a problem?

STAT

For a company moving as quickly as possible to build artificial intelligence into everything — including health care — Microsoft spends a lot of time talking about how to regulate it. The tech giant has helped organize four separate coalitions to devise guidelines and technical standards for AI in health care.

Hospitals 139
article thumbnail

Lawmakers urge White House officials to enforce sanctions on China's WuXi AppTec, WuXi Biologics: Reuters

Fierce Pharma

After introducing legislation targeting certain Chinese biopharma companies, a group of bipartisan lawmakers are taking their concerns to the White House—and upping the stakes.

122
122
article thumbnail

Planning strategies for transitioning to the Clinical Trials Regulation

pharmaphorum

There is a pressing need for companies to transition their EU clinical trials that are ongoing under the “old” regulatory framework of the Clinical Trials Directive to the Clinical Trials Regulation. The risk for those that don’t meet the 30th January 2025 deadline for transition is that they will lose their legal basis.

118
118
article thumbnail

Novo Nordisk To Cut Insulin Prices Up To 75%

Drug Topics

According to a company press release, the price reductions will go into effect at the start of 2024

187
187
article thumbnail

Prominent German trade union pushes back on potential Bayer split: Reuters

Fierce Pharma

As Bayer’s new CEO Bill Anderson kicks off his first full year at the helm with an objective to revamp the company, a prominent German trade union is pressing to keep the large conglomerate togethe | As new CEO Bill Anderson presses on with his strategic review, Germany's IG BCE is taking issue with potential German job losses that could stem (..)

98